Edgar Engleman

Edgar Engleman

Founder at Vivo Capital LLC

Net worth: 1 M $ as of 2024-04-29

78 year
Health Technology
Consumer Services
Finance

Profile

Edgar G.
Engleman
is the founder of Genelabs Technologies, Inc. (founded in 1984), Dendreon Corp.
(founded in 1992), CellGate Technologies LLC (founded in 1998), Cellgate, Inc. (founded in 1998), Neuraltus Pharmaceuticals, Inc. (founded in 2004), Medeor Therapeutics, Inc. (founded in 2013), Cetus Immune (founded in 1980), Dendreon Pharmaceuticals LLC (founded in 1992), Vivo Capital LLC (founded in 1996), and Bolt Biotherapeutics, Inc. (founded in 2015).
Dr. Engleman is also the founder of Tranquis Therapeutics, Inc., Neurocea LLC.
Dr. Engleman's current job(s) include being a Director at Semnur Pharmaceuticals, Inc., Director-Immunology & Immunotherapy Program at Stanford Cancer Institute, Director at Ossium Health, Inc., Director at Vivo Co-Invest (S) LP, and Professor at Stanford University School of Medicine (since 1990).
Dr. Engleman's former job(s) include being a Director at Insmed, Inc., Pepgen Corp., Prestwick Pharmaceuticals, Inc., Naryx Pharma, Inc., Soleno Therapeutics, Inc. (Director from 2001 to 2017), Eiger BioPharmaceuticals, Inc., REGENXBIO, Inc. (Independent Director from 2015 to 2016), Nuveta, Inc., Gryphon Therapeutics, Inc., Eiger BioPharmaceuticals, Inc. (Independent Director from 2016 to 2017), and Intermun, Inc.Dr. Engleman's education history includes undergraduate studies at Harvard University and a doctorate from Columbia University College of Physicians & Surgeons.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-03-27 1,220,281 ( 3.20% ) 1 M $ 2024-04-29

Edgar Engleman active positions

CompaniesPositionStart
Founder 1995-12-31
Stanford University School of Medicine Corporate Officer/Principal 1989-12-31
Director/Board Member -
Founder -
Vivo Co-Invest (S) LP Director/Board Member -
Director/Board Member -
All active positions of Edgar Engleman

Former positions of Edgar Engleman

CompaniesPositionEnd
BOLT BIOTHERAPEUTICS, INC. Founder 2024-05-14
SOLENO THERAPEUTICS, INC. Director/Board Member 2017-12-30
EIGER BIOPHARMACEUTICALS, INC. Director/Board Member 2017-09-17
░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░ ░░░░░░░ -
See the detail of Edgar Engleman's experience

Training of Edgar Engleman

Harvard University Undergraduate Degree
Columbia University College of Physicians & Surgeons Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Edgar Engleman's experience

Connections

100 +

1st degree connections

29

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies5
INSMED INCORPORATED

Health Technology

SOLENO THERAPEUTICS, INC.

Health Technology

REGENXBIO INC.

Health Technology

BOLT BIOTHERAPEUTICS, INC.

Health Technology

EIGER BIOPHARMACEUTICALS, INC.

Health Technology

Private companies21

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Electronic Technology

Health Technology

Health Technology

Health Technology

Health Services

Cetus Immune

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Vivo Co-Invest (S) LP

See company connections
  1. Stock Market
  2. Insiders
  3. Edgar Engleman